Domenico Gabrielli

Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting

M. Losi, G. Canciello, G. Todde, 2024, Frontiers in cardiovascular medicine.

Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population

C. Autore, G. Sinagra, F. Re, 2023, European journal of heart failure.